These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In vitro prevention of cell-mediated xeno-graft rejection via the Fas/FasL-pathway in CrmA-transducted porcine kidney cells. Fujino M; Li XK; Suda T; Hashimoto M; Okabe K; Yaginuma H; Mikoshiba K; Guo L; Okuyama T; Enosawa S; Amemiya H; Amano T; Suzuki S Xenotransplantation; 2001 May; 8(2):115-24. PubMed ID: 11328582 [TBL] [Abstract][Full Text] [Related]
6. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines. Arnold R; Seifert M; Asadullah K; Volk HD J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159 [TBL] [Abstract][Full Text] [Related]
7. Antitumor effects are produced by forced expression of membrane-bound but not soluble Fas ligand in murine lung carcinoma cells. Tada Y; O-Wang J; Seimiya M; Takiguchi Y; Tatsumi K; Kuriyama T; Tagawa M Anticancer Res; 2002; 22(2A):831-6. PubMed ID: 12014659 [TBL] [Abstract][Full Text] [Related]
8. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes. Brown SB; Savill J J Immunol; 1999 Jan; 162(1):480-5. PubMed ID: 9886423 [TBL] [Abstract][Full Text] [Related]
9. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity. Shimizu M; Fontana A; Takeda Y; Yoshimoto T; Tsubura A; Matsuzawa A Cell Immunol; 2001 Jan; 207(1):41-8. PubMed ID: 11161452 [TBL] [Abstract][Full Text] [Related]
10. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells. Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186 [TBL] [Abstract][Full Text] [Related]
11. Immune privilege or inflammation? The paradoxical effects of Fas ligand. O'Connell J Arch Immunol Ther Exp (Warsz); 2000; 48(2):73-9. PubMed ID: 10807046 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system. Jaber BL; Perianayagam MC; Balakrishnan VS; King AJ; Pereira BJ J Leukoc Biol; 2001 Jun; 69(6):1006-12. PubMed ID: 11404388 [TBL] [Abstract][Full Text] [Related]
16. A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplants. Kang SM; Braat D; Schneider DB; O'Rourke RW; Lin Z; Ascher NL; Dichek DA; Baekkeskov S; Stock PG Transplantation; 2000 May; 69(9):1813-7. PubMed ID: 10830216 [TBL] [Abstract][Full Text] [Related]
17. Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis. Kersemaekers AM; van Weeren PC; Oosterhuis JW; Looijenga LH J Pathol; 2002 Apr; 196(4):423-9. PubMed ID: 11920738 [TBL] [Abstract][Full Text] [Related]
18. Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis. Dick AD; Siepmann K; Dees C; Duncan L; Broderick C; Liversidge J; Forrester JV Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2258-67. PubMed ID: 10476791 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis provoked by the oxidative stress inducer menadione (Vitamin K(3)) is mediated by the Fas/Fas ligand system. Caricchio R; Kovalenko D; Kaufmann WK; Cohen PL Clin Immunol; 1999 Oct; 93(1):65-74. PubMed ID: 10497012 [TBL] [Abstract][Full Text] [Related]
20. Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients. Shimizu M; Kondo M; Ito Y; Kume H; Suzuki R; Yamaki K Cancer Detect Prev; 2005; 29(2):175-80. PubMed ID: 15829378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]